Last reviewed · How we verify
Emollient (moisturizer) — Competitive Intelligence Brief
phase 3
Emollient/Moisturizer
Dermatology
Small molecule
Live · refreshed every 30 min
Target snapshot
Emollient (moisturizer) (Emollient (moisturizer)) — Sanofi. An emollient moisturizer works by forming an occlusive barrier on the skin surface to reduce transepidermal water loss and restore skin hydration.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Emollient (moisturizer) TARGET | Emollient (moisturizer) | Sanofi | phase 3 | Emollient/Moisturizer |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Emollient/Moisturizer class)
- Sanofi · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Emollient (moisturizer) CI watch — RSS
- Emollient (moisturizer) CI watch — Atom
- Emollient (moisturizer) CI watch — JSON
- Emollient (moisturizer) alone — RSS
- Whole Emollient/Moisturizer class — RSS
Cite this brief
Drug Landscape (2026). Emollient (moisturizer) — Competitive Intelligence Brief. https://druglandscape.com/ci/emollient-moisturizer. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab